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Predicting renal survival in primary focal glomerulosclerosis There are clinical and pathological indicators that can
from the time of presentation. help the clinicians to predict renal failure in a patient
Background. To predict the risk of developing chronic renal with FGS. These are age at the time of presentation,failure in patients with primary focal glomerulosclerosis (FGS)
gender, amount of proteinuria, hypertension, renal dys-using predictors available at the time of presentation, a retro-
function, percentage of sclerosed glomeruli and intersti-spective analysis was performed on 111 patients who were diag-
nosed at Christchurch Hospital from 1965 to 1998. tial fibrosis, location of segmental sclerosis, mean glo-
Methods. The predictors of outcome included age, gender, merular diameter and presence of vascular sclerosis, and
systolic and diastolic blood pressure, serum albumin, plasma therapeutic response to prednisone [5–8]. Most of thesecreatinine, presence of hematuria, and amount of proteinuria
studies lack a quantitative model of survival, so it is(all at the time of presentation). An injury score (combination
not possible to estimate renal survival for an individualof percentage of sclerosed glomeruli and proportion of tubulo-
interstitial fibrosis) was derived from a review of the initial patient. An accurate estimation of prognosis is important
kidney biopsy. Log-logistic accelerated failure time parametric in many respects. First, prognostic information can be
models were used.
used to inform patients about the likely outcome of theirResults. The median renal survival was 16.4 years (Kaplan–
disease. Second, the prognosis of an individual patientMeier estimate). The best single variable model was that using
the proportion of tubulointerstitial fibrosis (global chi-square can be used as a guide for selecting therapeutic options.
55.99, P , 0.0001). However, inclusion of plasma creatinine An ability to predict those at “high risk” would aid the
significantly improved the fit of the model (global chi-square physician in selecting the patients most likely to benefit
65.04, P , 0.0001). This joint model was superior to the single-
from therapies, thus minimizing the exposure to toxicvariable model. Both of the models were validated using jack-
immunosuppressive medications in those patients notknifing.
Conclusion. For a patient with primary FGS, these models running a high risk of developing renal insufficiency.
can be used to predict the risk of developing chronic renal Third, prognostic assessments are useful in designing and
failure at any time and the median renal survival, given the evaluating randomized clinical trials [9].
proportion of tubulointerstitial fibrosis and plasma creatinine
We studied 111 patients with primary FGS to developat the time of presentation.
a quantitative approach to predict the development of
chronic renal failure from the data available at the time
of presentation.Primary focal glomerulosclerosis (FGS) constitutes 7
to 20% of glomerular lesions in children and adults pre-
senting with proteinuria, most often with the nephrotic METHODS
syndrome [1–4]. The prognosis of primary FGS is poor. We reviewed 165 case notes of patients diagnosed as
Only 40% of patients with FGS survive for more than having FGS from 1965 to 1998 at the Department of
10 years without developing end-stage renal failure [2]. Nephrology, Christchurch Hospital, Christchurch, New
Zealand. The Department of Nephrology at Christchurch
Hospital is the sole provider of specialty nephrologicalKey words: FGS, chronic renal failure, sclerosed glomeruli, tubuloin-
terstitial fibrosis. services for a catchment area population of 0.5 million
people in the South Island of New Zealand. Most ofReceived for publication February 11, 1999
these patients were Caucasians. The clinical records ofand in revised form July 12, 1999
Accepted for publication July 20, 1999 these patients were reviewed for the evidence of other
diseases such as reflux nephropathy, intravenous drug 1999 by the International Society of Nephrology
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abuse, or association with other renal pathologies. These teinuria of less than 300 mg/day was considered as remis-
sion. Persistent deterioration of renal function was de-patients were excluded (N 5 34), as were those without
fined as a rise of plasma creatinine of more than 0.1kidney biopsy (N 5 17) or with inadequate kidney biopsy
mmol/liter, but less than 0.5 mmol/liter, for more than(total number of glomeruli less than 13, N 5 3). There-
three months. Those patients who had had no remissionfore, a total of 111 patients with primary FGS was ana-
were grouped as persistent proteinuria. The patients wholyzed. The diagnosis of FGS was made on morphologic
had succumbed from other than a renal cause weregrounds from the kidney biopsy according to the criteria
grouped as nonrenal deaths.of the International Study of Kidney Diseases in Chil-
dren (presence of segmental and/or global glomerulo-
Statistical analysissclerosis on kidney biopsy) [10].
Descriptive data were expressed as mean (sd) or per-For each patient, all of the available data were exam-
centages. The overall renal survival was studied usingined. The following variables, all at the time of presenta-
Kaplan–Meier nonparametric life table survival analysis.tion, were noted: age, gender, systolic and diastolic blood
A comparison among the groups of the proportion ofpressure, 24-hour urine protein excretion, presence of
tubulointerstitial fibrosis and plasma creatinine was donehematuria, plasma creatinine, serum cholesterol, total
using Tarone–Ware statistics. For modeling survival, aserum protein, and albumin.
parametric model was chosen to enable prediction forKidney biopsy slides with hematoxylin and eosin
an individual patient for any specified time interval. The(H&E) stain, periodic acid-Schiff (PAS) stain, and im-
predictors considered for analysis were age, gender,munofluorescence were reviewed. The following param-
amount of proteinuria, serum albumin, total serum pro-eters were noted from each biopsy: total number of glo-
tein, serum cholesterol, plasma creatinine, presence ofmeruli, total number of globally sclerosed glomeruli,
hematuria, systolic and diastolic blood pressure (all attotal number of segmentally sclerosed glomeruli, and
the time of presentation), injury score, percentage ofproportion of tubulointerstitial fibrosis (IF). The per-
sclerosed glomeruli, and proportion of tubulointerstitialcentage of renal cortex with tubulointerstitial fibrosis
fibrosis on kidney biopsy. An accelerated failure timewas determined by the standard point counting method
model with a log logistic form was chosen after an initialusing an ocular grid (10 mm2 divided into 25 squares;
exploration of the data [11]. The predictors were usedKlarmann Rulings, Manchester, NH, USA). The per-
individually, and then forward stepping and backwardcentage of tubulointerstitial fibrosis was expressed as the
stepping were used to select predictors for a joint model.proportion of renal cortex involved.
Shrinkage of the coefficients was estimated by using theAn injury score was calculated for each patient from
heuristic method of van Houwelingen and le Cessie asthe kidney biopsy.
described by Harrell et al [9]. Jackknifing was then used
to produce shrunk coefficients, which should have greater
validity for future prediction than the original coefficients.
Jackknifing is a form of cross-validation [9] in which a
model is fitted N times (where N is the number of pa-
Injury score 5
1 N of segmentallysclerosed glomeruli1 N of globallysclerosed glomeruli2
total number
of glomeruli
1 IF tients), with one subject being omitted each time. The
jackknifed estimates derived from these runs provide
bias reduction, standard errors and these estimates show
These patients were grouped into five categories on shrinkage so that the model obtained does not suffer
the basis of the status of the patients when last seen. For from over-fitting. The main analyses were carried out
survival analysis, renal death was the event of interest, using BMDP [12], but SAS [13] was used for jackknifing
and the death of a patient for other reasons or the end of survival models. A computerized system for calculation
the study period (August 1998) was counted as censoring of the predictors for individual patients was developed
events. The categories were as follows: category 1, renal using MATHCAD [14] and Microsoft Excel [15].
death (N 5 49); category 2, remission (N 5 30); category
3, persistent deterioration of renal function till the end
RESULTSof study (N 5 18); category 4, persistent proteinuria but
normal renal function (N 5 9); and category 5, nonrenal Out of a total of 165 patients diagnosed with FGS,
death (N 5 5). 111 patients with primary FGS were included for final
analysis. The age at the time of kidney biopsy ranged
Definitions from 16 to 70 years, and the male to female ratio was
For the purpose of this study, renal death was defined 1.62:1. Patient characteristics are shown in Table 1.
as a persistent rise of plasma creatinine above 0.5 mmol/ The mean time between the diagnosis and the final
event was 6.9 (sd 6.84) years. The mean follow-up timeliter for more than three months. Twenty-four hour pro-
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Table 1. Patient characteristics at presentation (N 5 111)
Variable Mean sd Variable %
Age years 35.6 14.9 Microscopic hematuria 21
Serum albumin g/liter 39.3 8.37 Nephrotic range proteinuria 78
Plasma creatinine mmol/liter 0.13 0.07 Raised plasma creatinine .0.01 mmol/liter 48
Proteinuria g/day 4.92 3.99 Hypertension 47
Systolic BP mm Hg 145.8 20.4 Gender
Diastolic BP mm Hg 88.9 9.1 Male 63
Injury score 1.0 0.41 Female 37
Sclerosed glomeruli % 55 29
Proportion of tubulointerstitial fibrosis 0.45 0.16
Duration of clinical disease before kidney biopsy days 62 34
was 10.8 (sd 8.5) years. During the observation period,
49 patients (44%) developed renal death, and 30 patients
(29%) had a remission. Eighteen patients (16.2%) expe-
rienced relentless deterioration of kidney function, and
nine patients (8.1%) had persistent proteinuria with nor-
mal plasma creatinine during follow-up. There were 3
patients out of 111 (2.7%) who showed a “malignant
course.” They presented with proteinuria of more than
15 g/day with hypoalbuminemia (serum albumin ,25 g/
liter) with deterioration to end-stage renal disease within
3 to 4.8 years. Ischemic heart disease was the leading
cause of nonrenal deaths. Only 28 (25%) patients out
of 111 were treated with prednisone (1.0 mg/kg for 6 to
8 weeks followed by tapering depending on the response;
Fig. 1. Overall renal survival. The median renal survival was 16.4 years.
maximum duration for the treatment was not exceeding Five- and 10-year survivals were 76% and 62%, respectively. At 5, 10,
15, 20 years, there were 72, 43, 27, 15 patients, respectively, at risk ofmore than 12 weeks). Six patients responded to steroids
developing renal failure.(reduction in proteinuria to ,300 mg/day), and none
were treated with cyclophosphamide. The therapy was
individualized for every patient, but overall, the patients
with gross proteinuria (.8.0 g/day), hypoalbuminemia
influence of tubulointerstitial fibrosis on renal survival,
(serum albumin , 35 g/liter) with symptomatic nephrotic
the sample was divided into three groups based on thesyndrome, or deteriorating renal function were treated
proportion of tubulointerstitial fibrosis: group I, ,0.35;with prednisone. Sixty-one (55%) patients received an-
group II, 0.35 to 0.52; group III, .0.52. The renal survivalgiotensin-converting enzyme inhibitors over a period of
of the three groups is plotted using Kaplan–Meier esti-1.4 to 9 years for non-nephrotic range proteinuria or
mates (Fig. 2). Plasma creatinine (mmol/liter) was alsonephrotic range proteinuria with normal serum albumin
analyzed in a similar way after dividing the patients intoand stable renal function. The patients were regularly
three groups: group I, ,0.09; group II, 0.09 to 0.14; andfollowed up at the intervals of three months to two years,
group III, .0.14.depending on their clinical status. The duration of follow-
As shown in the Table 3, all of the variables, apartup ranged from 2 to 25 years.
from hematuria, individually predicted survival (P ,The median renal survival was 16.4 years (Fig. 1).
0.05). However, only two variables, proportion of tubulo-Before looking at the predictors of survival, the relation-
interstitial fibrosis and plasma creatinine, were selectedships between predictors were examined (Table 2). Be-
for the joint models. For prediction, it is important tocause of these relationships, it would be expected that
avoid overfitting, particularly with small samples, andsome predictors would not be required in a composite
thus only predictors that significantly improved the fitmodel because their effects could be accounted for by
were added to the model. The tubulointerstitial fibrosisother predictors, and an efficient and replicable model
model is the single best variable model for prediction.would include only one of the kidney histology variables.
Including plasma creatinine also improved the fit of theA parametric model was used, as prediction is not
model. The global chi-square for the two predictor modelpossible with nonparametric modeling. Of the possible
was 65.04 (P , 0.0001; shown in the Appendix for bothsingle predictors investigated, the best single predictor
was tubulointerstitial fibrosis (Table 3). To illustrate the of the models). Shrinkage in the joint model was only
Chitalia et al: Renal survival in primary FGS 2239
Table 2. Correlation matrix showing relationships between predictorsa
Sclerosed Systolic Diastolic
Injury glomeruli Tubulointerstitial 24-hour Serum Plasma blood blood
Predictors score % fibrosis proteinuria albumin creatinine pressure pressure
Injury score 1 0.95 0.81 0.26 0.54 0.45 0.33 0.23
Sclerosed glomeruli % 1 0.57 0.20 0.44 0.41 0.25 0.20
Tubulointerstitial fibrosis 1 0.29 0.57 0.38 0.38 0.30
24 hour proteinuria 1 0.30 0.21 0.27 0.23
Serum albumin 1 0.40 0.44 0.30
Plasma creatinine 1 0.40 0.31
Systolic blood pressure 1 0.49
Diastolic blood pressure 1
a Only significant correlations are reported (critical r $ 0.2 for N 5 111 and a2 5 0.05)
Table 3. Predictors of survival
Individual Predictors Joint predictors
Global Increase in
Predictors x2 P global x2 P
Tubulointerstitial
fibrosis 55.99 ,0.0001 55.99 ,0.0001
Plasma creatinine 24.13 ,0.0001 9.05 ,0.0026
Injury score 36.39 ,0.0001
Serum albumin 28.68 ,0.0001
Sclerosed
glomeruli % 20.22 ,0.0001
Systolic BP 11.27 0.0008
Diastolic BP 8.75 0.003
Proteinuria 6.82 0.009
Gender 5.0 0.04
Hematuria 0.19 0.66
Fig. 3. Plasma creatinine (mmol/liter) and renal survival. Plasma creat-
inine was divided into three groups. Symbols are: (r) plasma creatinine
,0.09 (N 5 31); (j) plasma creatinine 0.09 to 0.14 (N 5 40); and (d)
plasma creatinine .0.14 (N 5 40). The difference in the renal survival
was significant, P , 0.0001 (Tarone–Ware statistics).
terstitial fibrosis and 2.2% for plasma creatinine). The
coefficients in the Appendix are the jackknifed coeffi-
cients (Table 4 in the Appendix section). A software
program to use the survival models has been written in
Microsoft Excel to make it widely usable (available on
request). To illustrate the model, the predicted renal
survival curves from the model (two variable) for the
proportion of tubulointerstitial fibrosis from 0.1 to 0.4
and plasma creatinine (mmol/liter) from 0.1 to 0.8 are
shown in Figure 4.
Fig. 2. Tubulointerstitial fibrosis and renal survival. The tubulointersti-
tial fibrosis was divided into three groups. Symbols are: (j) tubulointer-
stitial fibrosis ,0.35 (N 5 35); (r) tubulointerstitial fibrosis 0.35 to 0.52 DISCUSSION
(N 5 37); and (d) tubulointerstitial fibrosis .0.52 (N 5 39). The
difference in renal survival was significant, P , 0.0001 (Tarone–Ware Primary FGS is a disease characterized by steroid-
statistics). resistant nephrotic syndrome, a frequently relapsing
course in 90% of the patients, renal function impairment
in more than 50%, and progression to end-stage renal
disease in 33% [16]. Previously, it has not been possible2%. Nonetheless, jackknifing was used to shrink the coef-
to predict the clinical outcome of an individual patientficients in order to improve the predictive validity. As
with primary FGS from the time of presentation [17–20].expected from the heuristic estimate of shrinkage, jack-
knifing produced only a small change (1.1% for tubuloin- We have developed mathematical models to predict the
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variables correlating with renal outcome, but none have
performed predictive renal survival analysis from the
significant variables.
An attempt to predict the risk of developing renal
failure in patients with primary membranous glomerulo-
nephritis was made by Pei, Cattaran, and Greenwood
by developing a mathematical model with persistent pro-
teinuria of specified duration, creatinine clearance dur-
ing that period, and slope of inverse creatinine versus
time curve as variables [23]. Various models were devel-
oped using different levels of proteinuria over varying
intervals of time. Persistent proteinuria was found to
be the single best model for predicting chronic renal
insufficiency. An approach for risk assessment of primary
membranous glomerulonephritis was also proposed on
Fig. 4. Predicted renal survival curves for various values of tubulointer- the basis of these three variables. Such modeling necessi-stitial fibrosis and plasma creatinine. Renal survival is predicted for
tates observation of a patient for some time before ascer-different combinations of tubulointerstitial fibrosis and plasma creati-
nine (mmol/liter). Symbols are: (—) for tubulointerstitial fibrosis and taining the risk of developing renal failure, which may
plasma creatinine of 0.1 and 0.1 mmol/liter, respectively; (- - - -) for 0.1 delay initiating the therapy. The prediction was madeand 0.3 mmol/liter, respectively; (- – - – -) for 0.4 and 0.3 mmol/liter,
with good accuracy; however, this model ignored therespectively; and (– – – –) for 0.4 and 0.8 mmol/liter, respectively.
time to renal failure and merely looked at the outcome
in a variable follow-up period. This means that the model
fails to take account of censoring so that its estimate
probability of developing chronic renal failure by analyz- may be biased. Furthermore, one can predict the proba-
ing 111 patients with primary FGS diagnosed at Christ- bility of renal failure, but the time of onset of renal
church Hospital from 1965 to 1998. Various clinical and failure cannot be predicted from such a model.
histological parameters were analyzed, and two models In this study, clinical and histological parameters as
have been developed by including the basic clinical and described in the literature were included for analysis.
histological data at the time of presentation. Obviously, the events that happen after the onset of
The median renal survival in this study during the disease such as the therapy, the response to it, and the
observation period was 16.4 years; 5 and 10 renal surviv- behavior of different predictors, for example, control of
als were 76% and 62%, respectively. The renal survival blood pressure with the therapy over time, can change
reported in the literature varies from a 10-year renal the outcome. The response to the therapy was not in-
survival of 45% in nephrotic patients to a 91% in non- cluded in the model as a variable because the intention
nephrotic patients to the least favorable of 25% in pa- was to develop the model from the information (bio-
tients with primary FGS [18, 21] chemical and kidney biopsy report) at the time of presen-
There are several studies assessing clinical and histo- tation (only a small number, 6 out of 28 patients, re-
logical features and the response to prednisone as pre- sponded to steroid therapy). On reviewing kidney
dictors for renal survival [5–8]. Velosa et al performed biopsies, an injury score was derived by taking into con-
renal survival analysis on 64 patients with primary FGS sideration sclerosed glomeruli and the proportion of in-
to ascertain factors at the time of kidney biopsy associ- terstitial fibrosis. There are a number of other histologi-
ated with progression to end-stage renal failure [22]. It cal variables described in the literature derived from
was shown that patients with proteinuria (.3.5 g/24 hr), morphometric analysis that are only practical in a re-
a higher initial plasma creatinine concentration, and se- search context [8]. Out of all of the histological pre-
vere tubulointerstitial damage had an accelerated course dictors, interstitial damage and some times percentage
to renal failure, whereas other variables studied were of sclerosed glomeruli have emerged as independent
not found to be associated with the time of end-stage variables correlating with renal outcome [6–8]. The clini-
renal disease. Shiki et al found tubulointerstitial change cal significance of the location of the glomerular scar
and mean glomerular diameter as independent risk fac- (including “tip” lesion) remains controversial [7, 8]. The
tors among clinical and morphological predictors consid- injury score used in this study was slightly different from
ered for renal outcome [6]. In a retrospective analysis that used by Raij, Azar, and Keane [24], which involved
performed by Schwartz et al on 81 patients with biopsy multiplying the degree of damage by the percentage of
proven FGS, interstitial fibrosis was the only histological glomeruli injured by the same extent. It has been shown
feature correlating with progression to end-stage renal that the exact quantitation of the percentage of glomeruli
affected and sclerosis of the glomerular tuft can be madedisease [8]. All of these studies have indicated many
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Table 4. The coefficients in the modelswith only the three-dimensional morphologic analysis of
electron micrographs, as sclerosed glomeruli in a given Coefficients
section can show more sclerosed changes in regions far Intercept Scale Tubulointerstitial Plasma
Model m s fibrosis creatininefrom the section of examination [25]. Hence, the injury
score considered in this study included only the number Overall survival 8.6214 0.8449 — —
Tubulointerstitialof sclerosed glomeruli and the proportion of interstitial
model 12.0713 0.6487 27.1276 —fibrosis, which could be obtained from the kidney biopsy
Two variable
report of a patient. model 12.1367 0.5869 25.8595 25.3233
Interdependency was noted among many predictors
(Table 2). The high correlation was found between injury
score, percentage of sclerosed glomeruli and tubulointer-
stitial fibrosis; injury score and serum albumin, plasma It is possible to predict renal survival from the propor-
tion of tubulointerstitial fibrosis and plasma creatininecreatinine; systolic blood pressure and diastolic blood
pressure, plasma creatinine, and serum albumin. These at the presentation. Predicting the renal survival and the
risk of developing end-stage renal disease from the datarelationships explain why the final model contains only
2 out of 10 variables found to be significant predictors. at the initial presentation of the disease offers the most
practical way of providing a prognosis and will help inAll of the histopathological markers (injury score, per-
centage of sclerosed glomeruli, proportion of tubuloin- individualizing the therapy from very beginning. In order
to simplify the application for clinical purpose, theseterstitial fibrosis) correlated with the renal survival to a
significant extent (P , 0.0001), but it was the tubulointer- models are developed on Microsoft Excel, which can be
easily used by all clinicians by entering in the values institial fibrosis that rendered the best predictive power
to the model (Table 3). Thus, the best single variable two models (available on request).
predicting renal survival was tubulointerstitial fibrosis.
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APPENDIX
The influence of tubulointerstitial fibrosis on survival
Most computer software packages use the log-linear representationcan also be seen in Figure 2. The tubulointerstitial fibrosis
of the accelerated failure time model [11]. In this formulation the
was further divided into three groups, the bottom group survival to time t for an individual is as follows:
having the least interstitial fibrosis, the middle group and
Si(t) 5 [1 1 exp{(logt 2 m 2 oai xi)/s}]the last group having more interstitial fibrosis. There was
where m is the intercept, s is the scale parameter, and a i is the coeffi-a statistically significant difference in the renal survival
cient for predictor xi.of patients with an tubulointerstitial fibrosis of less than Note that the log is the natural log and the time is in days.
For overall survival, there are no predictors, and thus, all that needs0.35 as compared with the other groups. Plasma creati-
to be entered is the time of interest.nine was similarly divided into three groups (Fig. 3). It
For prediction using the tubulointerstitial fibrosis model, there is
can be inferred that patients with a tubulointerstitial only one x, namely the proportion of tubulointerstitial fibrosis.
For prediction using the joint model, there are two x’s, namely thefibrosis of more than 0.35 and a plasma creatinine at the
proportion of tubulointerstitial fibrosis and plasma creatinine.time of presentation of more than 0.13 mmol/liter augurs
The median survival time is as follows:
a bad prognosis.
t(50) 5 exp(m 1 oai xi)The most stringent test of any model (and of the entire
data collection system) is an external validation: the ap- The coefficients in the models are given in Table 4.
For example, renal survival of a patient of FGS at 10 years (3652.5plication of the “frozen” model to a new population.
days) will be 0.621, and thus median survival will be 15.19 years. The
In this study, the models were internally validated by renal survival of same patient for the same time with tubulointerstitial
fibrosis of 0.5 and plasma creatinine 0.1 mmol/liter at the time ofjackknifing, which may suffice for external validation [9].
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